Bladder Cancer - Results from #8640

REVIEW UroToday

Nanoparticulation of BCG-CWS for application to bladder cancer therapy - Abstract March 20, 2014

Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort - Abstract March 20, 2014

Stratifying patients with haematuria into high or low risk groups for bladder cancer: A novel clinical scoring system - Abstract March 19, 2014

Immunotherapeutic strategies for bladder cancer - Abstract March 18, 2014

Pathologic response rates of gemcitabine/cisplatin versus methotrexate/vinblastine/adriamycin/cisplatin neoadjuvant chemotherapy for muscle invasive urothelial bladder cancer - Abstract March 18, 2014

Impact of provider volume on operative mortality after radical cystectomy in a publicly funded healthcare system - Abstract March 18, 2014

Tumor size and T stage correlate independently with recurrence and progression in high-risk non-muscle-invasive bladder cancer patients treated with adjuvant BCG - Abstract March 17, 2014

EAU guidelines on Muscle-invasive and Metastatic bladder cancer: Summary of the 2013 Guidelines - Abstract March 17, 2014

Prophylactic effects of Bacille Calmette-Guérin intravesical instillation therapy: Time period-related comparison between Japan and Western countries - Abstract March 17, 2014

Percutaneous cryotherapy for metastatic bladder cancer: Experience with 23 patients - Abstract March 15, 2014

Fistula between external iliac artery and ileal conduit after radical cystectomy: A life-threatening complication - Abstract March 14, 2014

Assessment of asymptomatic microscopic hematuria in adults - Abstract March 14, 2014

Combined chemoradiation therapy with twice-weekly gemcitabine and cisplatin for organ preservation in muscle-invasive bladder cancer: Long-term results of a phase 1 trial - Abstract March 14, 2014

Gender-specific survival following radical cystectomy for pT4 bladder cancer - Abstract March 13, 2014

Impact of preoperative immunonutrition on morbidity following cystectomy for bladder cancer: A case-control pilot study - Abstract March 12, 2014

FGFR3 overexpression is prognostic of adverse outcome for muscle-invasive bladder carcinoma treated with adjuvant chemotherapy - Abstract March 12, 2014

Nonresponse to neoadjuvant chemotherapy for muscle-invasive urothelial cell carcinoma of the bladder - Abstract March 11, 2014

Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC - Abstract March 11, 2014

Increased risk of urothelial cancer in young and middle aged patients with end-stage renal disease - Abstract March 10, 2014

Pharmacogenomics in bladder cancer - Abstract March 10, 2014

Page 433 of 517